Fall in HDL-cholesterol in diabetic patients treated with micronised fenofibrate therapy

被引：0
|
作者：
Hulme, SA
Furlong, NJ
Obrien, SV
Hardy, KJ
机构：
来源：
DIABETES | 2002年 / 51卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
2032
引用
收藏
页码：A495 / A495
页数：1
相关论文
共 50 条
  • [21] Relationship between serum magnesium and Hdl-cholesterol levels in diabetic patients with ischemic heart disease
    Kim, Mi Jin
    Chung, Choon Hee
    Lee, Yeon
    DIABETES, 2007, 56 : A667 - A667
  • [22] The effect of fenofibrate on HDL cholesterol and HDL particle concentration in postmenopausal women on tibolone therapy
    Stuckey, B. G. A.
    Barrett, P. H. R.
    Wagner, J. M.
    Hampton, R. A.
    Chan, D. C.
    Brown, S. J.
    Watts, G. F.
    CLINICAL ENDOCRINOLOGY, 2010, 73 (04) : 497 - 501
  • [23] Paradoxically decreased HDL-cholesterol levels associated with rosiglitazone therapy
    Gutschi, L. Maria
    Malcolm, Janine C.
    Favreau, Colette M.
    Ooi, Teik Chye
    ANNALS OF PHARMACOTHERAPY, 2006, 40 (09) : 1672 - 1676
  • [24] Association between Pemafibrate Therapy and Triglyceride to HDL-Cholesterol Ratio
    Imamura, Teruhiko
    Narang, Nikhil
    Kinugawa, Koichiro
    JOURNAL OF CLINICAL MEDICINE, 2022, 11 (10)
  • [25] HDL SUBFRACTION DISTRIBUTION IN HYPERTENSIVE PATIENTS WITH HIGH PLASMA HDL-CHOLESTEROL LEVELS
    Tellis, C.
    Benas, D.
    Triantafyllidi, H.
    Tselepis, A.
    ATHEROSCLEROSIS, 2021, 331 : E126 - E126
  • [26] Fenofibrate paradoxically increases plasma total cholesterol levels but not HDL-cholesterol levels in apo E-KO mice
    Yeganeh, B
    Jolodar, A
    Mueller, C
    Hourihane, AGS
    Moghadasian, MH
    JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 2004, 37 (01) : 293 - 294
  • [27] Fenofibrate/rosiglitazone interactionDecreased HDL cholesterol levels: 3 patients
    Reactions Weekly, 2008, 1223 (1) : 13 - 13
  • [28] The neutrophil/lymphocyte, neutrophil/HDL-cholesterol, and monocyte/HDL-cholesterol ratios as simple markers of low-grade inflammation in CKD patients
    Lajdova, Ingrid
    Spustova, Viera
    Wsolova, Ladislava
    Oksa, Adrian
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2024, 39 : I2351 - I2351
  • [29] Combination therapy with fenofibrate and rosiglitazone paradoxically lowers serum HDL cholesterol
    Normén, L
    Frohlich, J
    Montaner, J
    Harris, M
    Elliott, T
    Bondy, G
    DIABETES CARE, 2004, 27 (09) : 2241 - 2242
  • [30] The neutrophil/lymphocyte, neutrophil/HDL-cholesterol, and monocyte/HDL-cholesterol ratios as simple markers of low-grade inflammation in CKD patients
    Lajdova, Ingrid
    Spustova, Viera
    Wsolova, Ladislava
    Oksa, Adrian
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2024, 39
12345